The briefing
The Guardian reports that a new HIV prevention medication could substantially reduce cases globally, but access is being hampered by USAID funding cuts. Public health experts say the setback could slow progress in high-need regions.
Original headline
HIV prevention drug could reduce number of cases globally but USAID cuts prevent access, say experts